Sonnet Biotherapeutics Holdings IncEigentümerstruktur
| Preis (2025-12-02) | 52W Hoch | 52W Tief |
| 1.26 USD | 7,9 USD | 1,26 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 20 USD | 1 | 0 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 6.827.352 | 31,56 | 3,27 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Sonnet Biotherapeutics Holdings Inc
Mitarbeiter 13
Handelsplatz NASDAQ
Ticker Symbol SONN
IPO Datum 2006-10-31
Adresse 100 Overlook Center, Princeton, NJ, United States, 08540
Webseite https://www.sonnetbio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Raghu Rao | Interim CEO & Director |
| 2 | Dr. John K. Cini Ph.D. | Chief Scientific Officer & Co-Founder |
| 3 | Mr. Donald J. Griffith CPA, CPA | CFO & Director |
| 4 | Dr. Stephen J. McAndrew Ph.D. | President & Chief Business Officer |
| 5 | Dr. Gael Hedou Ph.D. | Chief Operating Officer |
| 6 | Ms. Susan Dexter | Chief Technical Officer |
| 7 | Dr. Richard T. Kenney FACP, M.D. | Chief Medical Officer |
| 8 | Mr. Manuel Dafonseca | Head of Clinical Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Mmcap International Inc. Spc | 0,00% | 0,00 Mio. USD |
| 2 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 3 | XTX Topco Ltd | 0,00% | 0,00 Mio. USD |
| 4 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 5 | Tower Research Capital LLC | 0,00% | 0,00 Mio. USD |
| 6 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 7 | Carolina Wealth Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 9 | Barclays PLC | 0,00% | 0,00 Mio. USD |
| 10 | Citigroup Inc | 0,00% | 0,00 Mio. USD |
| 11 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 12 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 13 | Virtu Financial LLC | 0,00% | 0,00 Mio. USD |